Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderately Hypofractionated Radiotherapy”

30 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 30 results

Not applicableLooking for participantsNCT07527689
What this trial is testing

Ultra-Hypofractionated vs Moderate Hypofractionated Radiotherapy for Regional Lymph Nodes in High Risk Breast Cancer

Who this might be right for
Breast Cancer
Ruijin Hospital 1,950
Not applicableLooking for participantsNCT07343531
What this trial is testing

Moderately Hypo-Fractionated External-beam Radiotherapy With Concurrent Chemotherapy and High Dose Rate Brachytherapy In Cervical Cancer

Who this might be right for
Cervical Carcinoma Stage IIICervical Carcinoma Stage IIBCervical Carcinoma Stage II
Ain Shams University 30
Not applicableActive Not RecruitingNCT03827616
What this trial is testing

Moderately Hypofractionated Radiotherapy for Prostate Cancer.

Who this might be right for
Prostatic NeoplasmsGenital Neoplasms
Tatarstan Cancer Center 400
Large-scale testing (Phase 3)Looking for participantsNCT07500701
What this trial is testing

Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer

Who this might be right for
Prostate Cancer
Samsung Medical Center 270
Not applicableUnknownNCT03833193
What this trial is testing

Moderate Hypofractionated Radiotherapy for Lung Cancer

Who this might be right for
Lung Cancer
North China Petroleum Bureau General Hospital 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06599827
What this trial is testing

Neoadjuvant Moderately Hypofractionated Radiotherapy Combined with Chemotherapy and Immunotherapy for High-risk LARC

Who this might be right for
Rectal Cancer
Shanghai Zhongshan Hospital 54
Not applicableLooking for participantsNCT07020780
What this trial is testing

5 fr Ultrahypofractionated WBI and SIB for Breast Cancer With Unfavorable Characteristics

Who this might be right for
Breast Cancer
IRCCS San Raffaele 458
Testing effectiveness (Phase 2)Study completedNCT03660449
What this trial is testing

Moderately Hypofractionated Conformal Radiation Combined With S-1 for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sun Yat-sen University 58
Not applicableActive Not RecruitingNCT02384733
What this trial is testing

Hypofractionated Loco-regional Adjuvant Radiation Therapy of Breast Cancer Combined With a Simultaneous Integrated Boost

Who this might be right for
LymphedemaFibrosis
Danish Breast Cancer Cooperative Group 2,963
Not applicableActive Not RecruitingNCT05994300
What this trial is testing

Moderately Hypofractionated Adaptive Radiotherapy for Cervical Cancer

Who this might be right for
Cervical NeoplasmAdaptive RadiotherapyRadiotherapy; Adverse Effect
Peking Union Medical College Hospital 30
Not applicableActive Not RecruitingNCT04262609
What this trial is testing

Faecal Incontinence in Prostate Cancer Survivors Treated Whith Radiotherapy

Who this might be right for
Faecal IncontinenceProstate Cancer
Consorci Sanitari de Terrassa 200
Not applicableLooking for participantsNCT07135661
What this trial is testing

Ultra-Hypofractionated vs. Moderately Hypofractionated Proton Therapy for Early Breast Cancer After Lumpectomy

Who this might be right for
Breast CancerProton Therapy
Shanghai Proton and Heavy Ion Center 312
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07527520
What this trial is testing

Neoadjuvant Moderately Hypofractionated Radiotherapy Combined With Chemotherapy and Immunotherapy for High-risk pMMR/MSS Locally Advanced Rectal Cancer: A Prospective, Multi-center Randomized Control Phase II Trial

Who this might be right for
Rectal CancerModerately Hypofractionated RadiotherapySerplulimab+1 more
Fudan University 165
Not applicableLooking for participantsNCT07792993
What this trial is testing

Focal Micro-boost Strategy in Patients With Intermediate- to High-risk Prostate Cancer (IR-HR PCa) Undergoing Hypofractionated Radiotherapy

Who this might be right for
Localized Prostate Cancer
Regina Elena Cancer Institute 82
Not applicableLooking for participantsNCT07684508
What this trial is testing

Adjuvant Moderately Hypofractionated Intensity-modulated Radiotherapy for Cervical Cancer

Who this might be right for
Hypofractionated RadiotherapyIntensity-modulated RadiotherapyCervical Cancers
Manni Huang 154
Not applicableLooking for participantsNCT07584161
What this trial is testing

MH-ART vs CF-IMRT in Postoperative Cervical/Endometrial Cancer

Who this might be right for
Cervical CancerEndometrial Cancer
Xiaorong Hou 228
Testing effectiveness (Phase 2)Study completedNCT06233981
What this trial is testing

Phase II Study of Moderate-dose Hypofractionated RT Combined With Tislelizumab for HCC With Diffuse Tumor Thrombosis

Who this might be right for
Hepatocellular CarcinomaRadiotherapyTislelizumab+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Not applicableLooking for participantsNCT06496256
What this trial is testing

Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial

Who this might be right for
Prostate Cancer
Palette Life Sciences, Inc. 84
Not applicableActive Not RecruitingNCT02307058
What this trial is testing

Randomized MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated Radiotherapy

Who this might be right for
Prostate Cancer
University of Miami 164
Not applicableLooking for participantsNCT07116213
What this trial is testing

Clinical Research on Moderately Hypofractionated Adaptive Postoperative Radiotherapy for High-Risk Endometrial Cancer

Who this might be right for
Endometrial CancerHypofractionated DoseRadiotherapy, Adjuvant+2 more
Xiaorong Hou 20
Next Page